When the Pressure Is High the Dementia Is Low
Sounds of Science Podcast
Tuning Up or Taming Immune Responses
New Immunotherapeutic Strategies Include Bispecific Antibodies, Engineered Adenoviruses, and Specifically Formulated Vaccines against Cancer
The Promise of Tumor Mutational Burden for Cancer Immunotherapy
Quantitative Biomarkers Could Be the Next Step for Precision Oncology
Just Enough Downstream Innovation
Downstream Operations Can Relieve the Pressure of Higher Titers and Cell Densities without Undue Disruption
- Dolomite Centre
- Unit 1, Anglian Business Park
- Orchard Rd.
- Royston , SG8 5TW
- UNITED KINGDOM
Dolomite has its roots in Syrris, which was founded in 2001 by Mark Gilligan and Richard Gray to address the challenges faced by the pharmaceutical industry. While Syrris focuses on flow chemistry and microreactors, Dolomite was set up as a subsidiary to provide microfluidic solutions to customers around the world in a very wide range of applications outside the field of research chemistry.